| RS730880942 |
MYL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 10, Cardiomyopathy |
| RS730880944 |
MYL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 10 |
| RS730880946 |
MYL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 10, Cardiovascular phenotype |
| RS730880948 |
MYL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 10, Cardiovascular phenotype |
| RS730880952 |
MYL2
|
Health Risk |
Likely pathogenic |
— |
| RS730880956 |
MYL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 8, Cardiomyopathy |
| RS730880960 |
MYL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS730880962 |
MYL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730880963 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS730880965 |
NRAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 6, Cardiovascular phenotype |
| RS730880967 |
NRAS
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS730880971 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Lethal congenital glycogen storage disease of heart |
| RS730880972 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital glycogen storage disease of heart, Cardiovascular phenotype |
| RS730880975 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolff-Parkinson-White pattern, Cardiomyopathy |
| RS730880978 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital glycogen storage disease of heart, Cardiomyopathy |
| RS730880987 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital glycogen storage disease of heart, Cardiomyopathy |
| RS730880989 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital glycogen storage disease of heart, Cardiomyopathy |
| RS730880998 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS730881000 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS730881002 |
RAF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome and Noonan-related syndrome, RASopathy |
| RS730881003 |
RAF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome, RASopathy |
| RS730881006 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, RASopathy |
| RS730881007 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS730881009 |
RAF1
|
Health Risk |
Likely pathogenic |
— |
| RS730881010 |
RAF1
|
Health Risk |
Likely pathogenic |
RASopathy, RASopathy |
| RS730881012 |
RIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 8, Noonan syndrome 8 |
| RS730881014 |
RIT1
|
Health Risk |
Pathogenic |
Noonan syndrome 8, Noonan syndrome |
| RS730881017 |
SHOC2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS730881019 |
SHOC2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome-like disorder with loose anagen hair 1 |
| RS730881020 |
SHOC2
|
Health Risk |
Pathogenic |
Noonan syndrome-like disorder with loose anagen hair 1, RASopathy |
| RS730881024 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS730881026 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome and Noonan-related syndrome |
| RS730881031 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS730881032 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, RASopathy |
| RS730881034 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Fibromatosis |
| RS730881035 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome 4 |
| RS730881036 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 4, Fibromatosis |
| RS730881038 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Fibromatosis |
| RS730881041 |
SOS1
|
Health Risk |
Likely pathogenic |
— |
| RS730881042 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome 4 |
| RS730881044 |
SOS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome 4, Fibromatosis |
| RS730881045 |
SOS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome, RASopathy |
| RS730881046 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS730881048 |
SOS1
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS730881051 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS730881053 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Fibromatosis |
| RS730881054 |
SOS1
|
Health Risk |
Pathogenic/Likely pathogenic |
RASopathy, Noonan syndrome |
| RS730881058 |
TNNC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z |
| RS730881059 |
TNNC1
|
Health Risk |
Likely pathogenic |
— |
| RS730881061 |
TNNC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 |
| RS730881063 |
TNNC1
|
Health Risk |
Likely pathogenic |
— |
| RS730881065 |
TNNC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z |
| RS730881066 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730881068 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS730881069 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS730881070 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730881071 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS730881075 |
TNNI3
|
Health Risk |
Likely pathogenic |
— |
| RS730881076 |
TNNI3
|
Health Risk |
Likely pathogenic |
— |
| RS730881077 |
TNNI3
|
Health Risk |
Pathogenic |
— |
| RS730881078 |
TNNI3
|
Health Risk |
Pathogenic |
TNNI3-related disorder, TNNI3-related disorder |
| RS730881079 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS730881081 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730881082 |
TNNI3
|
Health Risk |
Pathogenic |
— |
| RS730881083 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS730881085 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS730881086 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730881087 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 7, Dilated cardiomyopathy 1FF |
| RS730881090 |
TNNI3
|
Health Risk |
Likely pathogenic |
— |
| RS730881091 |
TNNI3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy |
| RS730881092 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy 2 |
| RS730881093 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Dilated cardiomyopathy 1D |
| RS730881096 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1D, Cardiomyopathy |
| RS730881097 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Dilated cardiomyopathy 1D |
| RS730881098 |
TNNT2
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D |
| RS730881101 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy 2 |
| RS730881103 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1D, Cardiomyopathy |
| RS730881104 |
TNNT2
|
Health Risk |
Likely pathogenic |
— |
| RS730881106 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1D, Cardiomyopathy |
| RS730881115 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1D, Cardiovascular phenotype |
| RS730881116 |
TNNT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS730881119 |
TNNT2
|
Health Risk |
Pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS730881120 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D |
| RS730881121 |
TNNT2
|
Health Risk |
Pathogenic |
— |
| RS730881122 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Dilated cardiomyopathy 1D |
| RS730881124 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1D, Cardiomyopathy |
| RS730881128 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS730881131 |
TPM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 3 |
| RS730881132 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS730881134 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730881136 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730881140 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS730881141 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS730881151 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 3, Cardiovascular phenotype |
| RS730881157 |
TPM1
|
Health Risk |
Pathogenic |
— |
| RS730881159 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730881160 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730881162 |
TTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hyperthyroxinemia |
| RS730881163 |
TTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyloidosis, hereditary systemic 1 |
| RS730881164 |
TTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyloidosis, hereditary systemic 1 |